πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 141 of 173

  1. US 7176280

    Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7175990

    Method of determining endometrial receptivity

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7172770

    Mesoporous compositions for use in drug delivery

    Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7172761

    Polyvalent immunogen

    Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7169384

    Tumor suppressor CAR-1

    Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7169594

    Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

    Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7169411

    Composition for delivery of biological agents and methods for the preparation thereof

    Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7166578

    Orally administered peptides synergize statin activity

    Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7166704

    Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer

    Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7166450

    Hyaluronan synthase gene and uses thereof

    Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7163925

    p16 expression constructs and their application in cancer therapy

    Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7163686

    Protein A based binding domains with desirable activities

    Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7163806

    Somatic cells with ablated PrP gene and methods of use

    Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7160720

    CHAMPβ€”a novel cardiac helicase-like factor

    Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7160722

    Master bone formation transcription factor: compositions and methods of use

    Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7157082

    Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase

    Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7157439

    HoxD3, HoxA3, and HoxB3 compositions and methods for improved wound healing

    Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7157435

    Methods for modulation of the effects of aging on the primate brain

    Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7153519

    Implantable substrate coated with a macromer having free radical polymerizable substituents

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7153514

    Use of botulinum toxin therapy for prostatic hyperplasia and related disorders

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7153509

    Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7153677

    Hyaluronan synthase gene and uses thereof

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7153838

    Pharmacologically acceptable solvent vehicles

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7153936

    Semaphorin gene family

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7153683

    TAO protein kinase polypeptides and methods of use therefor

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7150871

    Treatment of acute lung injury, fibrosis and metastasis with antagonists of Ξ±vΞ²6

    Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7151100

    Indole compounds useful for the treatment of cancer

    Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7148201

    Use of human plasma hyaluronidase in cancer treatment

    Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7148251

    Amino ceramide-like compounds and therapeutic methods of use

    Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7147863

    UVA (> 360-400) and UVB (300-325) specific sunscreens

    Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7148197

    Orally administered small peptides synergize statin activity

    Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7148196

    Anticancer compounds and methods

    Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7144880

    Compositions relating to novel compounds and targets thereof

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7144875

    Methods of treating fungal infections using lupeol

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7144723

    Marine actinomycete taxon for drug and fermentation product discovery

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7144982

    Polypeptides with therapeutic activity and methods of use

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7144862

    Orally administered peptides to ameliorate atherosclerosis

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7141233

    Radionuclide labeling of vitamin B12 and coenzymes thereof

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7141238

    Compositions for reducing UV-induced inhibition of collagen biosynthesis in human skin

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7141409

    Hyaluronan synthase gene and uses thereof

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7141405

    Chimeric GB virus B (GBV-B)

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7141603

    Antitumor agents

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7138569

    Nucleic acids encoding pseudomonas hop proteins and use thereof

    Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7138237

    Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

    Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7138384

    Modulators of DNA cytosine-5 methyltransferase and methods for use thereof

    Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7135176

    VMP-like sequences of pathogenic Borrelia

    Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7135453

    Reagents and methods for smooth muscle therapies

    Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7135192

    Cationic lipid compositions targeting angiogenic endothelial cells

    Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.